Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives

被引:31
作者
Lv, Kai [1 ,2 ]
Li, Linhu [1 ,2 ]
Wang, Bo [1 ,2 ]
Liu, Mingliang [1 ,2 ]
Wang, Bin [3 ]
Shen, Weiyi [4 ]
Guo, Huiyuan [1 ,2 ]
Lu, Yu [3 ]
机构
[1] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China
[2] Peking Union Med Coll, Beijing 100050, Peoples R China
[3] Capital Med Univ, Beijing TB & Thorac Tumor Res Inst, Beijing Key Lab Drug Resistance TB Res, Dept Pharmacol,Beijing ChestHosp, Beijing 101149, Peoples R China
[4] Zhejiang Starry Pharmaceut Co Ltd, Xianju 317300, Peoples R China
关键词
Imidazo[1,2-a]pyridine; Design; Synthesis; Antimycobacterial activity; RESISTANT MYCOBACTERIUM-TUBERCULOSIS; CLINICAL CANDIDATE; AGENTS; Q203;
D O I
10.1016/j.ejmech.2017.05.044
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report herein the design and synthesis of "novel imidazo [1,2-a]pyridine-3-carboxamides (IPAs)" bearing a variety of different linkers, based on the structure of IMB-1402 discovered in our lab. Results reveal that 2,6-dimethyl-N-[2-(phenylamino)ethyl] IPAs with an electron-donating group on the benzene ring as a potent scaffold. Compounds 26g and 26h have considerable activity (MIC: 0.041-2.64 mu M) against drug-sensitive/resistant MTB strains, and they have acceptable safety indices against MTB H37Rv with the SI values of 4395 and 1405, respectively. Moreover, N-[2-(piperazin-1-yl)ethyl] moiety was also identified as a potentially alternative linker (compound 31), opening a new direction for further SAR studies. (C) 2017 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:117 / 125
页数:9
相关论文
共 15 条
[1]   Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB [J].
Abrahams, Katherine A. ;
Cox, Jonathan A. G. ;
Spivey, Vickey L. ;
Loman, Nicholas J. ;
Pallen, Mark J. ;
Constantinidou, Chrystala ;
Fernandez, Raquel ;
Alemparte, Carlos ;
Remuinan, Modesto J. ;
Barros, David ;
Ballell, Lluis ;
Besra, Gurdyal S. .
PLOS ONE, 2012, 7 (12)
[2]  
Anderson L., 2015, GLOBAL TUBERCULOSI R
[3]   Bactericidal Activity of an Imidazo[1, 2-a]pyridine Using a Mouse M. tuberculosis Infection Model [J].
Cheng, Yong ;
Moraski, Garrett C. ;
Cramer, Jeffrey ;
Miller, Marvin J. ;
Schorey, Jeffrey S. .
PLOS ONE, 2014, 9 (01)
[4]   Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium [J].
Collins, LA ;
Franzblau, SG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) :1004-1009
[5]   New agents for the treatment of drug-resistant Mycobacterium tuberculosis [J].
Hoagland, Daniel T. ;
Liu, Jiuyu ;
Lee, Robin B. ;
Lee, Richard E. .
ADVANCED DRUG DELIVERY REVIEWS, 2016, 102 :55-72
[6]   Tuberculosis success [J].
Jones, Dan .
NATURE REVIEWS DRUG DISCOVERY, 2013, 12 (03) :175-176
[7]   Lead Optimization of a Novel Series of Imidazo[1,2-a]pyridine Amides Leading to a Clinical Candidate (Q203) as a Multi- and Extensively-Drug-Resistant Anti-tuberculosis Agent [J].
Kang, Sunhee ;
Kim, Ryang Yeo ;
Seo, Min Jung ;
Lee, Saeyeon ;
Kim, Young Mi ;
Seo, Mooyoung ;
Seo, Jeong Jea ;
Ko, Yoonae ;
Choi, Inhee ;
Jang, Jichan ;
Nam, Jiyoun ;
Park, Seijin ;
Kang, Hwankyu ;
Kim, Hyung Jun ;
Kim, Jungjun ;
Ahn, Sujin ;
Pethe, Kevin ;
Nam, Kiyean ;
No, Zaesung ;
Kim, Jaeseung .
JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (12) :5293-5305
[8]   MICROWAVE ASSISTED SYNTHESIS OF DISUBSTITUTED IMIDAZO[1,2-a]PYRIDINE-3-CARBOXYLIC ACID ESTERS [J].
Li, Lin-hu ;
Wu, Zhao-yang ;
Li, Zhuo-rong ;
Liu, Ming-liang ;
Guo, Hui-yuan ;
Zhang, Qiu-rong .
HETEROCYCLES, 2015, 91 (11) :2087-2096
[9]   Clofazimine Analogs with Efficacy against Experimental Tuberculosis and Reduced Potential for Accumulation [J].
Lu, Yu ;
Zheng, Meiqin ;
Wang, Bin ;
Fu, Lei ;
Zhao, Weijie ;
Li, Peng ;
Xu, Jian ;
Zhu, Hui ;
Jin, Haixia ;
Yin, Dali ;
Huang, Haihong ;
Upton, Anna M. ;
Ma, Zhenkun .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (11) :5185-5193
[10]   Advent of Imidazo[1,2-a]pyridine-3-carboxamides with Potent Multi- and Extended Drug Resistant Antituberculosis Activity [J].
Moraski, Garrett C. ;
Markley, Lowell D. ;
Hipskind, Philip A. ;
Boshoff, Helena ;
Cho, Sanghyun ;
Franzblau, Scott G. ;
Miller, Marvin J. .
ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (06) :466-470